Systems pharmacology strategies for drug discovery and combination with applications to cardiovascular diseases

被引:62
作者
Li, Peng [1 ,2 ]
Chen, Jianxin [3 ]
Wang, Jinan [1 ,2 ]
Zhou, Wei [2 ]
Wang, Xia [1 ,2 ]
Li, Bohui [1 ,2 ]
Tao, Weiyang [1 ,2 ]
Wang, Wei [3 ]
Wang, Yonghua [1 ,2 ]
Yang, Ling [4 ]
机构
[1] Northwest A&F Univ, Ctr Bioinformat, Yangling 712100, Shaanxi, Peoples R China
[2] Northwest A&F Univ, Coll Life Sci, Yangling 712100, Shaanxi, Peoples R China
[3] Beijing Univ Chinese Med, Beijing 100029, Peoples R China
[4] Chinese Acad Sci, Dalian Inst Chem Phys, Lab Pharmaceut Resource Discovery, Dalian, Liaoning, Peoples R China
基金
中国国家自然科学基金;
关键词
Cardiovascular diseases; Drug discovery and combination; Systems pharmacology; Systems biology; SIGNALING PATHWAYS; NETWORK MEDICINE; ABSORPTION; TARGET; MECHANISMS; BIOLOGY; PHARMACOKINETICS; METABOLISM; APOPTOSIS; THERAPY;
D O I
10.1016/j.jep.2013.07.001
中图分类号
Q94 [植物学];
学科分类号
071001 ;
摘要
Ethnopharmacological relevance: Multi-target therapeutics is a promising paradigm for drug discovery which is expected to produce greater levels of efficacy with fewer adverse effects and toxicity than monotherapies. Medical herbs featuring multi-components and multi-targets may serve as valuable resources for network-based multi-target drug discovery. Materials and methods: In this study, we report an integrated systems pharmacology platform for drug discovery and combination, with a typical example applied to herbal medicines in the treatment of cardiovascular diseases. Results: First, a disease-specific drug-target network was constructed and examined at systems level to capture the key disease-relevant biology for discovery of multi-targeted agents. Second, considering an integration of disease complexity and multilevel connectivity, a comprehensive database of literature-reported associations, chemicals and pharmacology for herbal medicines was designed. Third, a large-scale systematic analysis combining pharmacokinetics, chemogenomics, pharmacology and systems biology data through computational methods was performed and validated experimentally, which results in a superior output of information for systematic drug design strategies for complex diseases. Conclusions: This strategy integrating different types of technologies is expected to help create new opportunities for drug discovery and combination. (C) 2013 Published by Elsevier Ireland Ltd.
引用
收藏
页码:93 / 107
页数:15
相关论文
共 75 条
[21]   Analysis on outcome of 5284 patients with coronary artery disease: The role of integrative medicine [J].
Gao, Zhu-ye ;
Xu, Hao ;
Shi, Da-zhuo ;
Wen, Chuan ;
Liu, Bao-yan .
JOURNAL OF ETHNOPHARMACOLOGY, 2012, 141 (02) :578-583
[22]  
Grabowski K., 2007, Curr. Chem. Biol, V1, P115, DOI [10.2174/2212796810701010115, DOI 10.2174/2212796810701010115]
[23]   Chemogenomics: structuring the drug discovery process to gene families [J].
Harris, C. John ;
Stevens, Adrian P. .
DRUG DISCOVERY TODAY, 2006, 11 (19-20) :880-888
[24]   PEDF induces p53-mediated apoptosis through PPAR gamma signaling in human umbilical vein endothelial cells [J].
Ho, T. -C. ;
Chen, S. -L. ;
Yang, Y. -C. ;
Liao, C. -L. ;
Cheng, H. -C. ;
Tsao, Y. -P. .
CARDIOVASCULAR RESEARCH, 2007, 76 (02) :213-223
[25]   THE ROLE OF ARACHIDONIC-ACID IN RAT-HEART CELL-METABOLISM [J].
HOHL, CM ;
ROSEN, P .
BIOCHIMICA ET BIOPHYSICA ACTA, 1987, 921 (02) :356-363
[26]   Rosiglitazone evaluated for cardiovascular outcomes in oral agent combination therapy for type 2 diabetes (RECORD): a multicentre, randomised, open-label trial [J].
Home, Philip D. ;
Pocock, Stuart J. ;
Beck-Nielsen, Henning ;
Curtis, Paula S. ;
Gomis, Ramon ;
Hanefeld, Markolf ;
Jones, Nigel P. ;
Komajda, Michel ;
McMurray, John J. V. .
LANCET, 2009, 373 (9681) :2125-2135
[27]   The druggable genome [J].
Hopkins, AL ;
Groom, CR .
NATURE REVIEWS DRUG DISCOVERY, 2002, 1 (09) :727-730
[28]   Recent development and application of virtual screening in drug discovery: An overview [J].
Hou, TJ ;
Xu, XJ .
CURRENT PHARMACEUTICAL DESIGN, 2004, 10 (09) :1011-1033
[29]   Mechanisms of drug combinations: interaction and network perspectives [J].
Jia, Jia ;
Zhu, Feng ;
Ma, Xiaohua ;
Cao, Zhiwei W. ;
Li, Yixue X. ;
Chen, Yu Zong .
NATURE REVIEWS DRUG DISCOVERY, 2009, 8 (02) :111-128
[30]   Integrative genome-scale metabolic analysis of Vibrio vulnificus for drug targeting and discovery [J].
Kim, Hyun Uk ;
Kim, Soo Young ;
Jeong, Haeyoung ;
Kim, Tae Yong ;
Kim, Jae Jong ;
Choy, Hyon E. ;
Yi, Kyu Yang ;
Rhee, Joon Haeng ;
Lee, Sang Yup .
MOLECULAR SYSTEMS BIOLOGY, 2011, 7